Exploring overweight and obesity in pre-school children using routinely collected data: a case study of Halton,

C Perry1, M N Thurston2, B N Arch3

  • 1Alliance Manchester Business School, The University of Manchester, Manchester M15 6PB, UK.

Insights

Childhood overweight often begins in infancy. This study found higher rates of overweight infants in Halton, England, compared to UK-90 reference data, with increasing trends over time.

Area of Science:

  • Pediatric Health
  • Public Health
  • Growth Monitoring

Background:

  • Childhood overweight and obesity are significant public health concerns.
  • Evidence suggests early life factors influence later weight status.
  • Understanding infant weight patterns is crucial for early intervention.

Purpose of the Study:

  • To investigate weight patterns in children from birth to 40 months in Halton, UK.
  • To compare Halton infants' growth trajectories with UK-90 reference data.
  • To identify trends and gender differences in infant overweight and obesity.

Main Methods:

  • Analysis of 16,381 births between 1994 and 2006 in Halton.
  • Comparison of infant anthropometric data (heights and weights) with UK-90 reference population.
  • Calculation of age-sex adjusted SD scores and analysis of centile data using Poisson regression.

Main Results:

  • Halton infants showed consistently higher proportions above the 85th and 95th centiles at birth, 8 months, and 40 months compared to reference data.
  • While initial birth centiles remained stable, proportions above the 85th and 95th centiles increased significantly in later cohorts for other time points.
  • Cohort trends indicated a rise in infant overweight and obesity over successive birth years.

Conclusions:

  • The study provides evidence that the origins of overweight and obesity can be traced to early infancy.
  • Identified specific patterns of infant overweight and obesity in the Halton cohort.
  • Highlights the need for early life interventions to address childhood obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
339
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
751
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
282
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.3K